Cargando…
Efficacy and safety of duloxetine versus placebo in adolescents with juvenile fibromyalgia: results from a randomized controlled trial
BACKGROUND: Currently, there are no medications approved for the treatment of juvenile fibromyalgia (JFM). We evaluated the safety and efficacy of duloxetine 30/60 mg once daily (QD) versus placebo in adolescents with JFM. METHODS: In this Phase 3b, multisite (US, Argentina, Puerto Rico, and India)...
Autores principales: | Upadhyaya, Himanshu P., Arnold, Lesley M., Alaka, Karla, Qiao, Meihua, Williams, David, Mehta, Renata |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540374/ https://www.ncbi.nlm.nih.gov/pubmed/31138224 http://dx.doi.org/10.1186/s12969-019-0325-6 |
Ejemplares similares
-
Improvement in multiple dimensions of fatigue in patients with fibromyalgia treated with duloxetine: secondary analysis of a randomized, placebo-controlled trial
por: Arnold, Lesley M, et al.
Publicado: (2011) -
Duloxetine for the management of fibromyalgia syndrome
por: Scholz, Beth A, et al.
Publicado: (2009) -
Duloxetine: A Review of Its Safety and Efficacy in the Management of Fibromyalgia Syndrome
por: Smith, Howard S., et al.
Publicado: (2010) -
Efficacy and safety of duloxetine in the treatment of older adult patients with generalized anxiety disorder: a randomized, double-blind, placebo-controlled trial
por: Alaka, Karla J, et al.
Publicado: (2014) -
Effect of duloxetine in patients with fibromyalgia: tiredness subgroups
por: Bradley, Laurence A, et al.
Publicado: (2010)